News

• April 14, 2012
  

  Critical Path Institute Announces New Head of Operations

  Critical Path Institute (C-Path) has announced that Steven T. Broadbent has been chosen as the next chief operating officer of C-Path. Mr. Broadbent takes over for Rick Myers, who recently stepped down from C-Path in order to focus on his role as Chairman of the Arizona Board of Regents. Mr. Myers will continue to serve...
• April 14, 2012
  

  Future of medicine – the critical path forward

  I saw a presentation yesterday by Carolyn Compton, the new head of C-PATH, the critical path institute located in Tucson, AZ. This group has the goal of accelerating the development of new medicines by working at the interface between pharmaceutical companies, academic researchers and clinicians, the FDA, and the public.
• April 1, 2012
  

  House Energy and Commerce Committee Hearing

  C-Path’s work was positively acknowledged by Dr. Janet Woodcock during the April 18 House Energy and Commerce Committee Hearing. Congressman Engel (NY) posed a question about C-Path and the Critical Path Partnerships.
• March 25, 2012
  

  Critical Path Institute Announces New Board Members

  Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2012-2015). Joining the board are D. Craig Brater, MD, Dean, Indiana University School of Medicine; Samuel Broder, MD, Executive Vice President and Chief Medical Officer, Celera Genomics; James C. Greenwood, President and CEO of the...
• March 19, 2012
  

  Critical Path Institute Honors World Tuberculosis Day 2012

  Tuberculosis (TB) is often thought to be a disease of the past. The reality: Because no new therapies for TB have been developed in the past 50 years and treatment is long and complex, TB continues to kill 1.4 million people a year- someone every 20 seconds. Additionally, drug resistant forms of TB are an...